Targeted Exercise Prescription for Cardiac Rehabilitation
(PACE SETTER Trial)
Trial Summary
What is the purpose of this trial?
This trial is comparing two exercise plans for older adults with heart disease. One plan has a set goal, while the other lets participants decide their effort level. The goal is to see which plan improves fitness and health outcomes better.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment GXT+THHR, Graded Exercise Test + Target Heart Rate Range Prescription, in cardiac rehabilitation?
Research shows that using a Graded Exercise Test (GXT) to set a target heart rate for exercise in cardiac rehabilitation leads to greater improvements in exercise capacity compared to not using GXT. Patients who followed this method had a significant increase in their ability to exercise, as measured by metabolic equivalents of task (METs).12345
Is targeted exercise prescription for cardiac rehabilitation safe for humans?
How does the GXT+THHR treatment differ from other treatments for cardiac rehabilitation?
The GXT+THHR treatment is unique because it uses a graded exercise test to determine a personalized target heart rate for exercise, which has been shown to significantly improve exercise tolerance in cardiac rehabilitation compared to not using this method. This approach tailors the exercise intensity to each individual's capabilities, potentially leading to better outcomes.1391011
Research Team
Quinn Pack, MD
Principal Investigator
Baystate Medical Center
Eligibility Criteria
This trial is for older adults (60+) who've had a recent heart event like a heart attack, bypass surgery, or valve replacement and are eligible for cardiac rehab. They must live near Springfield, MA or Detroit, MI and commit to at least 18 rehab sessions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including 6MWT, SPPB, and psychological assessments
Treatment
Participants attend at least 18 sessions of cardiac rehabilitation, randomized to either GXT-THRR or RPE
Follow-up
Participants are monitored for long-term clinical outcomes and changes in physical performance
Treatment Details
Interventions
- GXT+THHR (Behavioural Intervention)
- RPE (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baystate Medical Center
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborator
Springfield College
Collaborator
University of Pennsylvania
Collaborator
Henry Ford Hospital
Collaborator